Related Experiment Videos
Nadolol as a treatment for akathisia
The American Journal of Psychiatry
|May 1, 1985
Abstract:
The authors present three cases of patients with neuroleptic-induced akathisia who were successfully treated with nadolol, a peripherally acting beta blocker. They discuss the potential implications of this finding.
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Unrecognized attention-deficit hyperactivity disorder in adults presenting for outpatient psychotherapy.
Journal of child and adolescent psychopharmacology·2009
Improvement of psoriatic onychodystrophy by a water-soluble nail lacquer.
Journal of the European Academy of Dermatology and Venereology : JEADV·2009
The effects of clozapine on severely aggressive psychiatric inpatients in a state hospital.
The Journal of clinical psychiatry·1993
The psychopharmacology of aggression: toward a new day.
Psychopharmacology bulletin·1993
Youth Autistic Traits and Brain Activation States During Socioemotional Processing.
The American journal of psychiatry·2026
Schizophrenia Beyond Genome-Wide Association Studies: It's About Time.
The American journal of psychiatry·2026
Determinants of Nonspecific Response to Treatment in Randomized Controlled Trials of Major Depressive Disorder: A Narrative Review.
The American journal of psychiatry·2026
Oral Semaglutide for Alcohol Use Disorder: A Randomized Clinical Trial.
The American journal of psychiatry·2026
Global Prevalence of Obsessive-Compulsive and Related Disorders: A Systematic Review and Modeling Study.
The American journal of psychiatry·2026
Metabolomic profiling of Ashwagandha (Withania somnifera): linking bioactive compounds to functional therapeutic roles.
Frontiers in molecular biosciences·2026
Qualitative analysis of a hands-on activity for urinary incontinence in a pharmacy therapeutics course.
Currents in pharmacy teaching & learning·2026
Cost analysis of radiotherapy equipment in public healthcare facilities of Tamil Nadu, South India.
Journal of cancer research and therapeutics·2026